EPISODE · Apr 28, 2026 · 1 MIN
The New Frontier in Neurological Research: Are GLP-1s Changing the Game?
from TheBrief.Health · host TheBrief.Health
GLP-1 receptor agonists are emerging as potential Alzheimer’s therapies, targeting metabolic dysfunction and inflammation, signaling a shift beyond amyloid-focused treatments despite mixed clinical trial results.
Embed this episode
NOW PLAYING
The New Frontier in Neurological Research: Are GLP-1s Changing the Game?
0:00
1:54
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of TheBrief.Health?
This episode is 1 minute long.
When was this TheBrief.Health episode published?
This episode was published on April 28, 2026.
Can I download this TheBrief.Health episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!